✦ LIBER ✦

Endogenous female prostate-specific antigen from female ejaculate may confound the use of prostate-specific antigen as a biomarker of exposure to semen

✍ Scribed by Masukume, Gwinyai

Book ID: 121500569
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 48 KB
Volume: 89
Category: Article
ISSN: 0010-7824
DOI: 10.1016/j.contraception.2013.10.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Effect of topical vaginal products on th

Effect of topical vaginal products on the detection of prostate-specific antigen, a biomarker of semen exposure, using ABAcards

✍ Snead, Margaret C.; Kourtis, Athena P.; Black, Carolyn M.; Mauck, Christine K.; 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 235 KB

Effect of lubricants and a vaginal sperm

Effect of lubricants and a vaginal spermicide gel on the detection of prostate specific antigen, a biomarker of semen exposure, using a quantitative (Abbott ARCHITECT) assay

✍ Snead, Margaret C.; Melendez, Johan H.; Kourtis, Athena P.; Chaney, Dorothy M.; 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 368 KB

Prostate-specific antigen as a biomarker

Prostate-specific antigen as a biomarker of condom failure: comparison of three laboratory assays and self-reported condom use problems in a randomized trial of female condom performance

✍ Terri Walsh; Lee Warner; Maurizio Macaluso; Ron Frezieres; Margaret Snead; Brian 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 149 KB

Use of the Percentage of Free Prostate-S

Use of the Percentage of Free Prostate-Specific Antigen to Enhance Differentiation of Prostate Cancer From Benign Prostatic Disease: A Prospective Multicenter Clinical Trial

✍ Catalona, W.J.; Partin, A.W.; Slawin, K.M.; Brawer, M.K.; Flanigan, R.C.; Patel, 📂 Article 📅 1999 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 213 KB

Use of prostate-specific antigen (PSA) t

Use of prostate-specific antigen (PSA) to measure semen exposure resulting from male condom failures: implications for contraceptive efficacy and the prevention of sexually transmitted disease

✍ Terri L Walsh; Ron G Frezieres; Karen Peacock; Anita L Nelson; Virginia A Clark; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Can prostate-specific antigen be used as

Can prostate-specific antigen be used as a valid end point to determine the efficacy of chemotherapy for advanced prostate cancer?

✍ B. Seckin; C. T. Anthony; B. Murphy; M. S. Steiner 📂 Article 📅 1996 🏛 Springer-Verlag 🌐 English ⚖ 444 KB

It is current practice in many clinical trials evaluating new chemotherapy regimens for the treatment of advanced prostate cancer to use prostate-specific antigen (PSA) decline as a response criteria with the assumption that the level of PSA reflects the efficacy of chemotherapy. Advanced prostate c